As the pharmaceutical industry grapples with geopolitical tensions, regulatory shifts, and technological disruption, the question of what constitutes a strong external partnership has never been more critical. We asked industry leaders across CDMOs, biotechs, and technology providers to share their
Merck has announced that Kai Beckmann will take over as Chair of the Executive Board and Chief Executive Officer on 1 May 2026. He will succeed Belén Garijo, who has led the company as CEO since 2021 and will remain
Moderna has officially launched its Innovation and Technology Centre (MITC) at the Harwell Science and Innovation Campus in Oxfordshire, UK. The facility will manufacture British-made mRNA respiratory vaccines to support the National Health Service (NHS) seasonal vaccination programmes. The MITC
Thermo Fisher Scientific Inc. has announced a collaboration with Dr. Park, an emerging viral vector contract development and manufacturing organisation (CDMO) in South Korea. The company has selected Thermo Fisher to provide advanced bioreactors and consumables for its newest facility,
FUJIFILM Biotechnologies has officially opened its new manufacturing site in Holly Springs, North Carolina, marking the first phase of a planned $3.2 billion investment. The facility is one of the largest commercial-scale cell culture biomanufacturing sites in North America. The
The Ritedose Corporation has announced a $17 million investment to expand its in-house cGMP laboratory facilities, enhancing both analytical chemistry and microbiology capabilities. The project will add 10,000 square feet of laboratory space and provide advanced analytical services to support
Artificial intelligence (AI) agents could dramatically accelerate clinical drug development, delivering 35 to 45 percent productivity gains across all clinical functions while cutting trial design timelines in half, according to a comprehensive analysis from McKinsey & Company. The consulting firm’s
Hovione and Microinnova Engineering have announced a partnership to advance the development and testing of modular manufacturing equipment for flow chemistry. The collaboration focuses on creating multi-purpose, plug-and-play equipment designed to enhance process development and accelerate the transition from lab-scale
SyVento BioTech has announced a strategic partnership with Kymos Group aimed at delivering comprehensive solutions for RNA-based therapeutics. The collaboration combines SyVento’s preclinical and clinical drug development, liposomal and LNP technologies, and GMP manufacturing expertise with Kymos’ advanced bioanalytical and
SHL Medical has formed a non-exclusive strategic partnership with Lyophilization Technology, Inc. (LTI), a contract development and manufacturing organisation (CDMO) specialising in lyophilisation of healthcare products. The agreement, part of SHL’s alliance partnership framework, will focus on advancing lyophilised injectable
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
